Kuantum Papers Ltd Q4 FY26 Earnings Analysis

- Kuantum Papers expects gradual sales volume growth, targeting 2.35 lakh tons by FY 2028 from 1.6 lakh tons in FY 2025. - Revenue target for FY 2027 is around INR 1,800 crores with an EBITDA of approximately INR 300 crores. - The company anticipates improvement in pricing and margins in FY 2026-27 due to industry revival and price hikes. - Demand in writing and printing paper is growing at about 6% CAGR, supported by government focus on education. - Future capacity expansion includes a 50 tons per day tissue paper machine with INR 70-80 crores capex, planned over 16-18 months. - Import insulation measures like Minimum Import Price (MIP) are expected to help the domestic industry against competition. - Capacity addition in tissue and packaging grades is growing faster, but writing and printing segment sees limited new capacity, supporting steady demand absorption.

- Kuantum Papers expects an uptrend in operations and improved EBITDA margins, having bottomed out in the current cycle. - For FY 2026-27, the company targets a topline of around INR 1,800 crores and EBITDA of approximately INR 300 crores. - These targets are based on expected price hikes combined with volume growth. - EBITDA margins are expected to improve gradually, potentially reaching around 20%-22% over the next few years, though a 30% margin is considered ambitious. - Capacity expansions, including a new PM 3 machine startup and tissue paper plant plans, will support volume growth, targeting sales volumes up to 2.35 lakh tons by FY 2027-28. - Continuous cost initiatives and operational efficiencies under Project Nirmaan and Industry 4.0 transformation are anticipated to enhance profitability. - Improved pricing environment and moderation in raw material costs (e.g., wheat straw) are expected to support margin recovery. - Overall, the company is confident about sustained earnings growth and stronger cash flows to manage debt and fund future growth.

- Current capex underway includes upgrading PM 2 (INR45 crores) and PM 3 (INR140 crores), part of an overall INR735 crores expansion plan. - These upgrades involve temporary shutdowns: about 30 days for PM 2 and 45 days for PM 3. - Future capex plans include setting up a tissue paper machine with a capacity of 50 tons per day. - Estimated investment for the tissue paper plant is INR70-80 crores. - Implementation time for the tissue paper machine is around 16 to 18 months after sourcing. - No current plans for additional capex beyond ongoing projects, but the company may consider new opportunities if they arise. - The capex is financed through bank loans and internal accruals; peak long-term debt expected around INR750 crores.

- No immediate plans for new capex or fundraising currently; management stated, "Not at the moment," but may consider if an opportunity arises (Page 13). - Peak long-term debt expected to be around INR 750 crores; current long-term debt approximately INR 600 crores (Page 7). - Company expects to generate sufficient internal accruals from ongoing projects to service debt and repayment obligations without requiring additional borrowing (Page 12). - Focus will be to prepay and reduce debt significantly post-capex completion, leveraging strengthened cash flows (Page 12). - No mention of any new equity fundraising or share buybacks planned; promoter prefers increasing shareholder value through growth rather than buybacks currently (Page 14). - Overall, no new fundraising through debt or equity is planned in the near term; internal accruals and existing financing are considered adequate.

The transcript from Kuantum Papers Limited's Q3 FY '26 Earnings Conference Call does not explicitly mention details about the current or expected order book or any pending orders. The discussion primarily revolves around: - Industry outlook and pricing trends - Capacity expansion and capex plans, including upgrades to Paper Machines (PM 2 and PM 3) and potential new tissue paper plant - Government policies and trade agreements impacting the sector - Production volumes and EBITDA expectations - Market demand growth and pricing environment No specific data or commentary on current order book size or pending orders was provided during the call.